Mattias Sandström Selected Research

Carcinoma (Carcinomatosis)

1/2023	EANM enabling guide: how to improve the accessibility of clinical dosimetry.
3/2007	Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattias Sandström Research Topics

Disease

36	Neoplasms (Cancer) 05/2023 - 03/2007
14	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2012
6	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2007
6	Prostatic Neoplasms (Prostate Cancer) 07/2013 - 05/2011
5	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2010
2	Carcinoma (Carcinomatosis) 01/2023 - 03/2007
1	Pheochromocytoma 06/2019
1	Paraganglioma (Paragangliomas) 06/2019
1	Neuroblastoma 12/2017
1	Thyroid Diseases (Thyroid Disease) 12/2017
1	Neuroendocrine Carcinoma 01/2012
1	Disease Progression 01/2012

Drug/Important Bio-Agent (IBA)

18	Radioisotopes (Radionuclides)IBA 05/2023 - 02/2009
10	lutetium Lu 177 dotatateIBA 05/2023 - 02/2015
9	Peptide Receptors (Peptide Receptor)IBA 05/2023 - 02/2015
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 02/2009
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2011
7	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2015 - 03/2007
6	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2023 - 01/2013
4	Peptides (Polypeptides)IBA 05/2023 - 01/2013
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 07/2013 - 05/2011
4	Trastuzumab (Herceptin)FDA Link 11/2011 - 03/2007
3	LigandsIBA 01/2020 - 03/2007
3	gallium Ga 68 dotatateIBA 01/2020 - 10/2013
3	Ga(III)-DOTATOCIBA 01/2020 - 10/2013
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 10/2013
3	AndrogensIBA 03/2012 - 11/2011
3	Chelating AgentsIBA 03/2012 - 11/2007
2	ABY-025IBA 01/2016 - 11/2011
2	Biomarkers (Surrogate Marker)IBA 10/2015 - 07/2010
2	Bombesin Receptors (Bombesin Receptor)IBA 07/2013 - 01/2013
2	BombesinIBA 07/2013 - 01/2013
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2012 - 03/2012
2	Pentetic Acid (DTPA)FDA LinkGeneric 11/2011 - 08/2008
1	Aligeron (AS 2)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	His-His-His-His-His-His ((His)6)IBA 01/2019
1	SirtuinsIBA 07/2016
1	Cys-ZHER2-342 affibodyIBA 01/2016
1	68Ga-ABY-025IBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Peptide Nucleic AcidsIBA 01/2016
1	Oncogene Proteins (Oncogene Protein)IBA 10/2015
1	Insulin (Novolin)FDA Link 02/2015
1	Edotreotide (SMT 487)IBA 02/2014
1	IsotopesIBA 07/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2012
1	Lysine (L-Lysine)FDA Link 12/2008
1	IndiumIBA 11/2007
1	mercaptoacetyl-Glu-Glu-GluIBA 11/2007
1	GalliumIBA 11/2007
1	N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA 03/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2007
1	RadiopharmaceuticalsIBA 03/2007
1	tanespimycin (17AAG)IBA 03/2007

Therapy/Procedure

23	Therapeutics 05/2023 - 07/2010
5	Gamma Cameras (Gamma Camera) 11/2014 - 03/2007
4	Radiotherapy 05/2020 - 07/2016
2	Microspheres (Microsphere) 01/2023 - 12/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
1	Precision Medicine 10/2015
1	Intravenous Injections 05/2014